CNDP2 and pancreatic neoplasm: Some researchers demonstrated that the loss of a specific cytoband, 18q22.3, which encompasses only five genes, including the carboxypeptidase of glutamate-like (CPGL) gene, is linked to a poorer prognosis in both a testing cohort and an independent validation cohort of surgically resected pancreatic cancers.